All lobbying filings

ALLIANCE FOR REGENERATIVE MEDICINE

Lobbying for ALLIANCE FOR REGENERATIVE MEDICINE · Advocacy organization supporting advances in regenerative medicine.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $140,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 5

S 752
Accelerating Kids’ Access to Care Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 932
Give Kids a Chance Act of 2025
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 891
Bipartisan Health Care Act

Lobbying activity 1

Health Issues

Advocate on issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products. Value Based Payment legislation. CMS policies regarding Value Based legislation. FDA appropriations. FDA staffing. Prescription Drug User Fee Act (PDUFA). Medicaid reimbursement. Provider credentialing. Medicare reimbursement. NTAP. Reintroduction of Medicaid VBPs for Patients (MVP) Act. Accelerating Kids Access to Care Act (S. 752 / H.R.1509). MDRP. CMMI. Give Kids a Chance Act (S. 932 / H.R. 1262). Rare Pediatric Disease Designation and Priority Review Voucher (PRV) Programs. Reintroduction of the Patient Access Act. Bipartisan Health Care Act (S. 891). NIH Funding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.